NYXH

NYXH

USD

Nyxoah SA Ordinary Shares

$5.870+0.010 (0.171%)

Цена в режиме реального времени

Healthcare
Medical Instruments & Supplies
Бельгия

График цен

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$5.860

Максимум

$6.058

Минимум

$5.850

Объем

0.00M

Фундаментальные показатели компании

Рыночная капитализация

228.1M

Отрасль

Medical Instruments & Supplies

Страна

Belgium

Статистические данные торговли

Средний объем

0.13M

Биржа

NGM

Валюта

USD

52-недельный диапазон

Минимум $5.55Текущая $5.870Максимум $12.21

Связанные новости

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

Просмотреть больше
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Analyst Upgrades

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14

Stifel analyst Jonathan Block maintains Nyxoah with a Buy and lowers the price target from $15 to $14.

Просмотреть больше
Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14
GlobeNewswire

Conditional Issuance of Shares

INSIDE INFORMATIONREGULATED INFORMATION Conditional Issuance of Shares Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"),

Просмотреть больше
Conditional Issuance of Shares
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

Просмотреть больше
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target

HC Wainwright & Co. analyst Edward White reiterates Nyxoah with a Buy and maintains $15 price target.

Просмотреть больше
HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target
GlobeNewswire

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter Mont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET –

PR Newswire

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nyxoah S.A....

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.